Business Wire

RevBio Receives Both FDA Approval to Expand its Clinical Trial and CMS Reimbursement for its Regenerative Bone Adhesive for Cranial Flap Fixation

LOWELL, Mass.--(BUSINESS WIRE)--RevBio, Inc., announced that it has received FDA approval to expand its ongoing clinical trial to immediately fixate cranial flaps using TETRANITE ®, the company’s bone ...
Healio

Comment on rotational lamellar scleral flap technique

Please provide your email address to receive an email when new articles are posted on . We agree that the scleral lamellar flap can be rotated to cover the dehiscence and give a good outcome after ...
Yahoo Finance

RevBio Expands Globally into the United Kingdom with its Second Cranial Flap Fixation Clinical Trial for its Regenerative Bone Adhesive

This Clinical Trial will Demonstrate the Use of TETRANITE ® to Reintegrate Cranial Bone Flaps for Improved Clinical Outcomes "The background scientific work coupled with the promising recruitment thus ...
EurekAlert!

Chinese Neurosurgical Journal Study unveils absorbable skull device that speeds healing

Researchers at Central South University and MedArt developed a biodegradable cranial fixation device that strengthens bone healing, reduces complications, and offers a safer alternative to traditional ...
Business Wire

RevBio Receives FDA Approval to Conduct a First-in-Human Clinical Trial for its Regenerative Bone Adhesive for Cranial Flap Fixation

LOWELL, Mass.--(BUSINESS WIRE)--RevBio, Inc., announced that it has received approval from the U.S. Food and Drug Administration to start a 20-patient pilot clinical trial to examine the safety and ...
Finanznachrichten

RevBio, Inc.: RevBio Expands Globally into the United Kingdom with its Second Cranial Flap Fixation Clinical Trial for its Regenerative Bone Adhesive

This Clinical Trial will Demonstrate the Use of TETRANITE to Reintegrate Cranial Bone Flaps for Improved Clinical Outcomes RevBio, Inc., announced that it has received approval from the Medicines and ...